Skip to content

Drug interactions

Atazanavir + Linagliptin

Severity: Minor

Atazanavir and Linagliptin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Atazanavir inhibits CYP3A4 and P-gp and may raise linagliptin levels, though linagliptin is mostly eliminated unchanged and the increase is rarely important. Protease inhibitors can also impair glucose tolerance, which may work against glycemic control.

What this interaction means in plain words

Atazanavir and Linagliptin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Atazanavir belongs to Anti Virals; Linagliptin belongs to Endocrine.

Evidence level: Low

Why it happens

CYP3A4 and P-gp inhibition by atazanavir raises linagliptin exposure, while protease inhibitor related insulin resistance may raise glucose.

What to do

No linagliptin dose change is required; monitor blood glucose and HbA1c in patients on antiretroviral therapy.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Atazanavir and Linagliptin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Atazanavir with Linagliptin?

MediHelp rates the interaction as minor. Atazanavir and Linagliptin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Atazanavir inhibits CYP3A4 and P-gp and may raise linagliptin levels, though linagliptin is mostly eliminated unchanged and the increase is rarely important. Protease inhibitors can also impair glucose tolerance, which may work against glycemic control.

How serious is the interaction between Atazanavir and Linagliptin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No linagliptin dose change is required; monitor blood glucose and HbA1c in patients on antiretroviral therapy.

What other medicines interact with Linagliptin?

MediHelp also lists interactions of Linagliptin with, for example, Alogliptin-pioglitazone, Amlodipine-benazepril, Amobarbital. The full list is on the Linagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in